CoChat

Child and Adolescent Obsessive-Compulsive Disorder Treated with Citalopram: Findings from an Open Trial of 23 Cases

THOMSEN, PER HOVE · 1997 · Journal of Child and Adolescent Psychopharmacology
Cited by 89

The DOI matches its Crossref record.

Abstract

The adverse effects and potential clinical value of citalopram, a highly selective serotonin reuptake inhibitor, were examined in 23 children and adolescent (9-18 years old, 11 boys) with obsessive-compulsive disorder (OCD) in an open-label trial of citalopram 10-40 mg (modal 40 mg) daily. After 10 weeks of citalopram treatment, statistically significant improvements were reflected in OCD symptom ratings (mean Total Y-BOCS/CY-BOCS scores, 30 +/- 4 vs. 21 +/- 4, p < 0.001) and global assessment scores (mean CGAS, 59 +/- 11 vs. 71 +/- 11, p < 0.001). Over 75% of these youth showed a marked improvement (4 patients had more than 50% reduction in CY-BOCS scores) or moderate improvement (14 patients had 20%-50% reduction) in OCD symptoms. No patient was found to have worsened during citalopram treatment. Adverse effects appeared minor and transient. None of the 23 patients dropped out of the study or had the medication discontinued because of side effects. These open trials of citalopram do not allow for any firm conclusions regarding its effectiveness in the treatment of childhood and adolescent OCD, but these preliminary findings suggest that citalopram might be particularly well-tolerated in children and adolescents with OCD at doses up to 40 mg daily.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.1997.7.157

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
THOMSEN, P. H.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
1997-01
Volume
7
Issue
3
Pages
157-166
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2058070691
Cited by
89
References
0
FWCI
12.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.